30-Minute Price Action
NVDA is trading in a tight consolidation range near $183.86, repeatedly testing resistance without a confirmed breakout.
* Resistance: $183.86 – multiple tests with no close above, forming the top of the range.
* Support: $182.06 – intraday pivot; $179.11 – deeper support and prior demand zone.
* Indicators:
* MACD is flat, reflecting indecision and reduced momentum.
* Stoch RSI is mid-range, suggesting room for either a breakout or a fade depending on market catalysts.
1-Hour GEX Insights
* Highest Positive NET GEX / Gamma Wall: $183.86 – matches perfectly with 30m resistance, showing strong hedging activity.
* Call Walls Above: $187.5 (2nd gamma wall), $190 (major call wall & 3rd gamma level).
* Put Support: $177.5 (1st defense), $175 (stronger floor), $172.5 (secondary gamma floor).
* IVR: 16.2 – relatively low implied volatility rank, keeping long option premiums reasonable.
TA + GEX Combined Read
The 30m chart’s repeated tests of $183.86 line up exactly with the largest GEX wall on the 1h chart.
* A breakout above $183.86 could trigger gamma-driven momentum into $187.5 and potentially $190 if volume supports.
* A rejection at $183.86 could bring a retest of $182.06, and if that fails, a move toward $179.11 and $177.5 GEX support.
Trading Scenarios for August 13
* Bullish Breakout: Long calls or debit spreads above $184 targeting $187.5–$190.
* Bearish Rejection: Puts or put spreads if $183.86 rejects and $182.06 breaks, targeting $179.11–$177.5.
* Neutral Range: Credit spreads between $179–$184 may work if consolidation continues, but be ready to close early on breakout.
Reasoning The 30m chart’s tight range reflects market indecision, but the 1h GEX data highlights $183.86 as a key pivot for tomorrow. Breaks above this level open the path to the next gamma cluster, while rejection keeps NVDA in range or triggers a pullback toward strong GEX-supported floors.
NVDA is trading in a tight consolidation range near $183.86, repeatedly testing resistance without a confirmed breakout.
* Resistance: $183.86 – multiple tests with no close above, forming the top of the range.
* Support: $182.06 – intraday pivot; $179.11 – deeper support and prior demand zone.
* Indicators:
* MACD is flat, reflecting indecision and reduced momentum.
* Stoch RSI is mid-range, suggesting room for either a breakout or a fade depending on market catalysts.
1-Hour GEX Insights
* Highest Positive NET GEX / Gamma Wall: $183.86 – matches perfectly with 30m resistance, showing strong hedging activity.
* Call Walls Above: $187.5 (2nd gamma wall), $190 (major call wall & 3rd gamma level).
* Put Support: $177.5 (1st defense), $175 (stronger floor), $172.5 (secondary gamma floor).
* IVR: 16.2 – relatively low implied volatility rank, keeping long option premiums reasonable.
TA + GEX Combined Read
The 30m chart’s repeated tests of $183.86 line up exactly with the largest GEX wall on the 1h chart.
* A breakout above $183.86 could trigger gamma-driven momentum into $187.5 and potentially $190 if volume supports.
* A rejection at $183.86 could bring a retest of $182.06, and if that fails, a move toward $179.11 and $177.5 GEX support.
Trading Scenarios for August 13
* Bullish Breakout: Long calls or debit spreads above $184 targeting $187.5–$190.
* Bearish Rejection: Puts or put spreads if $183.86 rejects and $182.06 breaks, targeting $179.11–$177.5.
* Neutral Range: Credit spreads between $179–$184 may work if consolidation continues, but be ready to close early on breakout.
Reasoning The 30m chart’s tight range reflects market indecision, but the 1h GEX data highlights $183.86 as a key pivot for tomorrow. Breaks above this level open the path to the next gamma cluster, while rejection keeps NVDA in range or triggers a pullback toward strong GEX-supported floors.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.